Danimarca - danese - Adama

adama - 200 g/l fluroxypyr - herbicider

Danimarca - danese - SEGES Landbrug & Fødevarer

adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr

Unione Europea - danese - EMA (European Medicines Agency)

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout præparater - febuxostat mylan er indiceret til forebyggelse og behandling af hyperurikæmi hos voksne patienter, der gennemgår kemoterapi for hæmatologiske maligniteter ved mellemliggende risici for tumor lysis syndrome (tls). febuxostat mylan er indiceret til behandling af kronisk hyperuricaemia i forhold, hvor urat deposition har allerede fundet sted (herunder en historie, eller tilstedeværelsen af, tophus og/eller arthritis urica). febuxostat mylan er indiceret hos voksne.

Danimarca - danese - SEGES Landbrug & Fødevarer

dow agrosciences danmark a/s - ioxynil, clopyralid, fluroxypyr - emulsionskoncentrat - 120 g/l ioxynil ; 30 g/l clopyralid ; 100 g/l fluroxypyr

Danimarca - danese - SEGES Landbrug & Fødevarer

dow agrosciences danmark a/s - ioxynil, clopyralid, fluroxypyr - granulat - 120 g/l ioxynil ; 30 g/l clopyralid ; 100 g/l fluroxypyr

Danimarca - danese - SEGES Landbrug & Fødevarer

adama northern europe b.v. - florasulam, fluroxypyr - suspoemulsion - 2,5 g/l florasulam ; 100 g/l fluroxypyr

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - everolimus - tabletter - 10 mg

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - everolimus - tabletter - 5 mg

Unione Europea - danese - EMA (European Medicines Agency)

pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - immunostimulants, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 og 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. med hensyn til beslutningen om at indlede behandling hos pædiatriske patienter, se afsnit 4. 2, 4. 4 og 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 og 5. for at hepatitis c virus (hcv) genotype specifik aktivitet, se afsnit 4. 2 og 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. når det besluttes at indlede behandling i barndommen, er det vigtigt at overveje, væksthæmning, der er fremkaldt af en kombination terapi. reversibilitet af væksthæmning er usikker. beslutningen om at behandling skal ske på grundlag af en individuel vurdering (se afsnit 4.

Danimarca - danese - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - carbamazepin - depottabletter - 400 mg